A citation-based method for searching scientific literature

Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
Jennifer C Thompson, Jenny Harris, Andrea C Sollom, Cheryl L Stopford, Elizabeth Howard, Julie S Snowden, David Craufurd. J Neuropsychiatry Clin Neurosci 2012
Times Cited: 123



Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Sarah J Tabrizi, Rachael I Scahill, Gail Owen, Alexandra Durr, Blair R Leavitt, Raymund A Roos, Beth Borowsky, Bernhard Landwehrmeyer, Chris Frost, Hans Johnson, David Craufurd, Ralf Reilmann, Julie C Stout, Douglas R Langbehn. Lancet Neurol 2013
Times Cited: 536




List of shared articles



Times cited

Apathy and Depression in Huntington's Disease: Distinct Longitudinal Trajectories and Clinical Correlates.
Michael H Connors, Armando Teixeira-Pinto, Clement T Loy. J Neuropsychiatry Clin Neurosci 2023
1

Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients.
Jesús Ruiz-Idiago, Edith Pomarol-Clotet, Raymond Salvador. Parkinsonism Relat Disord 2023
0

Apathy and Huntington's Disease: A Literature Review Based on PRISMA.
Jihene Matmati, Christophe Verny, Philippe Allain. J Neuropsychiatry Clin Neurosci 2022
2

Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.
Lee-Anne Morris, Claire O'Callaghan, Campbell Le Heron. Mov Disord 2022
5

Psychotropic medication use in Huntington's disease: A retrospective cohort study.
Ruben L Andriessen, Mayke Oosterloo, Angelique Hollands, David E J Linden, Bianca T A de Greef, Albert F G Leentjens. Parkinsonism Relat Disord 2022
0

Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease.
Duncan James McLauchlan, Thomas Lancaster, David Craufurd, David E J Linden, Anne E Rosser. Brain Commun 2022
2

Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington's disease.
Duncan James McLauchlan, David E J Linden, Anne E Rosser. Front Neurosci 2022
0

Measuring Functional Status in Huntington's Disease.
Jessie S Gibson, Sheila H Ridner, Mary S Dietrich, Michael B Sohn, Bethany A Rhoten, Daniel O Claassen. Mov Disord 2021
2

Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington disease.
Marta Olivetti Belardinelli, Thomas Hünefeldt, Roberta Meloni, Ferdinando Squitieri, Sabrina Maffi, Simone Migliore. Exp Brain Res 2021
2

Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.
Kelly J Atkins, Sophie C Andrews, Trevor T-J Chong, Julie C Stout. Mov Disord Clin Pract 2021
7

Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease.
Audrey E De Paepe, Alberto Ara, Clara Garcia-Gorro, Saül Martinez-Horta, Jesus Perez-Perez, Jaime Kulisevsky, Nadia Rodriguez-Dechicha, Irene Vaquer, Susana Subira, Matilde Calopa,[...]. Mov Disord 2021
2

Endophenotypical drift in Huntington's disease: a 5-year follow-up study.
Marie N N Hellem, Rebecca K Hendel, Tua Vinther-Jensen, Ida U Larsen, Troels T Nielsen, Lena E Hjermind, Esben Budtz-Jørgensen, Asmus Vogel, Jørgen E Nielsen. Orphanet J Rare Dis 2021
3

Another Perspective on Huntington's Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD.
Jannis Achenbach, Carsten Saft. Brain Sci 2021
3

A Systematic Review of Neuropsychiatric Symptoms and Functional Capacity in Huntington's Disease.
Jessie Sellers, Sheila H Ridner, Daniel O Claassen. J Neuropsychiatry Clin Neurosci 2020
10

Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.
Natalie Ellis, Amelia Tee, Branduff McAllister, Thomas Massey, Duncan McLauchlan, Timothy Stone, Kevin Correia, Jacob Loupe, Kyung-Hee Kim, Douglas Barker,[...]. Biol Psychiatry 2020
14

Dissociable Motivational Deficits in Pre-manifest Huntington's Disease.
Kelly J Atkins, Sophie C Andrews, Julie C Stout, Trevor T-J Chong. Cell Rep Med 2020
8

Obsessive-Compulsive and Perseverative Behaviors in Huntington's Disease.
Mayke Oosterloo, David Craufurd, Hanneke Nijsten, Erik van Duijn. J Huntingtons Dis 2019
8

Insensitivity to loss predicts apathy in huntington's disease.
Duncan J McLauchlan, Thomas Lancaster, David Craufurd, David E J Linden, Anne E Rosser. Mov Disord 2019
11

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease.
Audrey E De Paepe, Joanna Sierpowska, Clara Garcia-Gorro, Saül Martinez-Horta, Jesus Perez-Perez, Jaime Kulisevsky, Nadia Rodriguez-Dechicha, Irene Vaquer, Susana Subira, Matilde Calopa,[...]. Neuroimage Clin 2019
21

A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice.
Christopher J Heath, Claire O'Callaghan, Sarah L Mason, Benjamin U Phillips, Lisa M Saksida, Trevor W Robbins, Roger A Barker, Timothy J Bussey, Barbara J Sahakian. Front Neurol 2019
13

The psychopharmacology of Huntington disease.
Åsa Petersén, Patrick Weydt. Handb Clin Neurol 2019
6

Progress in developing transgenic monkey model for Huntington's disease.
Brooke R Snyder, Anthony W S Chan. J Neural Transm (Vienna) 2018
10

Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
Mário Sousa, Fradique Moreira, Joana Jesus-Ribeiro, Inês Marques, Flávia Cunha, Nádia Canário, António Freire, Cristina Januário. Eur Neurol 2018
8

Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.
Nora E Fritz, Nicholas R Boileau, Julie C Stout, Rebecca Ready, Joel S Perlmutter, Jane S Paulsen, Kimberly Quaid, Stacey Barton, Michael K McCormack, Susan L Perlman,[...]. J Neuropsychiatry Clin Neurosci 2018
27

Structural and metabolic brain correlates of apathy in Huntington's disease.
Saul Martínez-Horta, Jesús Perez-Perez, Frederic Sampedro, Javier Pagonabarraga, Andrea Horta-Barba, Mar Carceller-Sindreu, Beatriz Gomez-Anson, Gloria Andrea Lozano-Martinez, Diego Alfonso Lopez-Mora, Valle Camacho,[...]. Mov Disord 2018
25

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study.
Verena Baake, Emma M Coppen, Erik van Duijn, Eve M Dumas, Simon J A van den Bogaard, Rachael I Scahill, Hans Johnson, Blair Leavitt, Alexandra Durr, Sarah J Tabrizi,[...]. Neuroimage Clin 2018
10

Beyond emotion recognition deficits: A theory guided analysis of emotion processing in Huntington's disease.
Catarina C Kordsachia, Izelle Labuschagne, Julie C Stout. Neurosci Biobehav Rev 2017
21

Investigational agents for the management of Huntington's disease.
Thomas Müller. Expert Opin Investig Drugs 2017
7

Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.HttQ111/+ model of Huntington's disease.
Robert M Bragg, Sydney R Coffey, Rory M Weston, Seth A Ament, Jeffrey P Cantle, Shawn Minnig, Cory C Funk, Dominic D Shuttleworth, Emily L Woods, Bonnie R Sullivan,[...]. Sci Rep 2017
10

Bupropion for the treatment of apathy in Huntington's disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.
Harald Gelderblom, Torsten Wüstenberg, Tim McLean, Lisanne Mütze, Wilhelm Fischer, Carsten Saft, Rainer Hoffmann, Sigurd Süssmuth, Peter Schlattmann, Erik van Duijn,[...]. PLoS One 2017
31

The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
Lynette J Tippett, Henry J Waldvogel, Russell G Snell, Jean-Paul Vonsattel, Anne B Young, Richard L M Faull. Adv Neurobiol 2017
4

Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease.
Roland Wiest, Jean-Marc Burgunder, Claus Kiefer. Front Neurol 2017
0

The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
58

Screening for cognitive dysfunction in Huntington's disease with the clock drawing test.
Paul W Terwindt, Anna A M Hubers, Erik J Giltay, Rose C van der Mast, Erik van Duijn. Int J Geriatr Psychiatry 2016
4

Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, Ramon Fernandez-Bobadilla, Mar Carceller, Javier Pagonabarraga, Berta Pascual-Sedano, Antonia Campolongo, Jesus Ruiz-Idiago, Frederic Sampedro,[...]. Parkinsonism Relat Disord 2016
90

Changes in mental state and behaviour in Huntington's disease.
Clare M Eddy, Ellice G Parkinson, Hugh E Rickards. Lancet Psychiatry 2016
49

Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.
Claudia Rangel-Barajas, George V Rebec. J Huntingtons Dis 2016
24

Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington's Disease.
Ida Unmack Larsen, Tua Vinther-Jensen, Jørgen Erik Nielsen, Anders Gade, Asmus Vogel. PLoS Curr 2016
5

Mouse Models of Huntington's Disease.
Simon P Brooks, Stephen B Dunnett. Curr Top Behav Neurosci 2015
17

Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies.
Jenny Callaghan, Cheryl Stopford, Natalie Arran, Marie-Francoise Boisse, Allison Coleman, Rachelle Dar Santos, Eve M Dumas, Ellen P Hart, Damian Justo, Gail Owen,[...]. J Neuropsychiatry Clin Neurosci 2015
55

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment.
Javier Pagonabarraga, Jaime Kulisevsky, Antonio P Strafella, Paul Krack. Lancet Neurol 2015
251


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy